Annual report pursuant to Section 13 and 15(d)

Common Stock Warrants (Tables)

v3.21.1
Common Stock Warrants (Tables)
12 Months Ended
Dec. 31, 2020
Equity [Abstract]  
Schedule of Warrants to Purchase Common Stock Outstanding

The following is a summary of information about our warrants to purchase common stock outstanding at December 31, 2020.

 

Shares Underlying Warrants Outstanding     Shares Underlying Warrants Exercisable  
         
Range of
Exercise
Prices
    Shares
Underlying
Warrants
Outstanding
    Weighted
Average
Remaining
Contractual
Life
  Weighted
Average
Exercise
Price
    Shares
Underlying
Warrants
Exercisable
    Weighted
Average
Exercise
Price
 
                                         
$ 0.25       7,511,650     4.59 years   $ 0.25       7,511,650     $ 0.25  
Schedule of Fair value Assumption of Warrants

The fair value of each warrant grant is estimated on the date of grant using the Black-Scholes option pricing model with the following weighted-average assumptions used for grants under the fixed option plan:

 

    December 31,     December 31,  
    2020     2019  
             
Average risk-free interest rates     0.30 %     N/A  
Average expected life (in years)     5.00       N/A  
Volatility     305 %     N/A  
Schedule of Warrants Activity

The following is a summary of activity of outstanding common stock warrants:

 

          Weighted  
          Average  
    Number     Exercise  
    of Shares     Price  
Balance, December 31, 2019     -     $            -  
Warrants granted     7,511,650       0.25  
Warrants exercised     -       -  
                 
Balance, December 31, 2020     7,511,650     $ 0.25  
                 
Exercisable, December 31, 2020     7,511,650     $ 0.25